Clinical Trial Update: Safety Study to Evaluate BMS-830216 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety study of BMS-830216 in healthy subjects to assess safety, tolerability, and pharmacokinetics; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BMS-830216

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Obesity | Phase 1 | Status: COMPLETED